Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.

Pilapitiya, Devaki; Wheatley, Adam K; Tan, Hyon-Xhi

Pilapitiya, Devaki; Wheatley, Adam K; Tan, Hyon-Xhi.

Afiliación

Pilapitiya D; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia.
Wheatley AK; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia.
Tan HX; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia. Electronic address: hxtan@unimelb.edu.au.

EBioMedicine ; 92: 104585, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37146404

Asunto(s)

COVID-19; Vacunas; Humanos; Vacunas contra la COVID-19; SARS-CoV-2; COVID-19/prevención & control; Membrana Mucosa; Vacunación; Inmunidad Mucosa; Anticuerpos Antivirales

Palabras clave

Adaptive immunity; Mucosal immunity; Respiratory viruses; Vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google